Skip to main content

Table 1 Distribution of patients by country (ITT population)

From: Randomized, active-controlled, comparative phase 3 efficacy and safety equivalence trial of Ovaleap® (recombinant human follicle-stimulating hormone) in infertile women using assisted reproduction technology (ART)

Country Ovaleap® (n = 153) Gonal-f® (n = 146) Total (N = 299)
Belgium + Germanya 35 30 65
Czech Republic 30 28 58
Hungary 39 38 77
Poland 49 50 99
  1. a3 patients were randomized in Belgium: 1 to Gonal-f® and 2 to Ovaleap®